Financial News
All News about Lexaria Bioscience Corp. - Common Stock

Lexaria Granted Two New DehydraTECH Patents for Treatment of Epilepsy
February 11, 2025
Via ACCESS Newswire

Lexaria Biodistribution Study For DehydraTECH GLP-1 is Underway
February 06, 2025
Via ACCESS Newswire

Lexaria Updates its Ongoing Human Study GLP-1-H24-4
February 05, 2025
Via ACCESS Newswire

Lexaria Releases Annual Letter from the CEO
January 30, 2025
Via ACCESS Newswire

Via ACCESSWIRE


Lexaria Bioscience Earnings Analysis: Q1 Recap
January 10, 2025
Via Benzinga

Lexaria's Registered GLP-1 Study #4 Begins Dosing
December 19, 2024
Via ACCESSWIRE

Lexaria Forms New Scientific Advisory Board
December 18, 2024
Via ACCESSWIRE


Via ACCESSWIRE


Lexaria's GLP-1 Human Pilot Study #3 Completes Dosing as Scheduled
November 25, 2024
Via ACCESSWIRE

Lexaria Signs Contract For New DehydraTECH GLP-1 Biodistribution Study
November 14, 2024
Via ACCESSWIRE


Lexaria Updates Fast-Moving GLP-1 'Arm's Race' Developments
November 07, 2024
Via ACCESSWIRE




Lexaria's GLP-1 Human Pilot Study #3 Begins Dosing
October 09, 2024
Via ACCESSWIRE



Lexaria Updates Current GLP-1 Market
October 08, 2024
Via ACCESSWIRE
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.